Heathy Casa

Stay updated with news, ideals and new technology for your health!

Month: June 2018

Nectar Foods Inc Dba Honey Mama's Issues Allergy Alert on Undeclared Almonds in Oregon Peppermint Cacao Nectar Bar

Nectar Foods Inc., DBA Honey Mama’s of Portland, Oregon is recalling 79 Sleeves (948 units) of Oregon Peppermint bars, lot code 112918, because it may contain undeclared almonds.  People who have an allergy or severe sensitivity to almonds run the risk of serious or life-threatening allergic reaction if they consume this product.
Oregon Peppermint Bars were distributed in Arkansas, California, Delaware, Florida, Georgia, Louisiana, Massachusetts, New Jersey, New York, North Carolina, Ohio, Oregon, Texas, Utah, Virginia, Vermont, Washington & Wisconsin through retail stores and website sales through HoneyMamas.com between June 1st, 2018 & June 21st, 2018.
The product can be identified by name & label listing flavor as Oregon Peppermint. The label is blue with white script & a dark blue Honey Mama’s hummingbird logo. Bars are wrapped in brown freezer paper and sealed with label, measuring 3×3 inches, & approximately 8mms thick. Product UPC is 8 54835 00402 9. Bars are refrigerated or frozen, with expiration code 112918 is printed on white label on reverse of bar.
No illnesses have been reported to date related to this recall.
The recall was initiated after it was discovered that product containing almonds was distributed in packaging that did not reveal the presence of almonds.
This recall is being made with the knowledge of the U.S. Food & Drug Administration.
Consumers who have purchased the affected Honey Mama’s Oregon Peppermint bars, & have an allergy or severe sensitivity to almonds, are urged to return it to the place of purchase for a full refund or destroy product.
Consumers with…

NLM Technical Bulletin, May-Jun 2018, TOXMAP Update: New Version Replaces Classic & Beta Versions

Table of Contents: 2018 MAY–JUNE No. 422
Previous Next
TOXMAP Update: New Version Replaces Classic & Beta Versions. NLM Tech Bull. 2018 May-Jun;(422):b10.
2018 June 22 [posted]
[Editor’s Note: This In Brief is based on an announcement published as an NLM Toxicology & Environmental Health Information email update from the NLM Division of Specialized Information Services. To automatically receive news on resources, services, & outreach in toxicology and environmental health please see the subscribe page.]
On June 20, 2018, new version of TOXMAP was released; it does not require browser plug-ins & provides improved usability on mobile devices.
The new TOXMAP has several updated datasets, including:
The previous versions of TOXMAP, TOXMAP classic & the Beta version of TOXMAP, will be retired on June 28, 2018.

NLM Technical Bulletin, May-Jun 2018, MeSH on Demand: New Tutorial Available

MeSH on Demand: New Tutorial Available. NLM Tech Bull. 2018 May-Jun;(422):b11.
2018 June 22 [posted]
The National Library of Medicine (NLM) is pleased to announce a new video tutorial, MeSH on Demand: Finding MeSH Terms in Your Text.
MeSH on Demand is a tool that uses the NLM Medical Text Indexer (MTI) to identify relevant Medical Subject Heading (MeSH) terms in text of up to 10,000 characters. The tool enables users to create their own set of MeSH terms for any text, as well as use those terms to perform custom PubMed searches. The tutorial describes the tool’s interface, & explains its output & principles of operation.
For more information on MeSH on Demand, see MeSH on Demand Update.
This tutorial & many other tutorials are available from the MeSH Learning Resources page & the NLM Learning Resources Database. …

NLM Technical Bulletin, May-Jun 2018, MLA 2018: NLM Update PowerPoint Presentations

MLA 2018: NLM Update PowerPoint Presentations. NLM Tech Bull. 2018 May-Jun;(421):e4b.
The NLM Update was held at the Annual Meeting of the Medical Library Association in Atlanta, GA, on May 30, 2018. Three speakers presented on NLM & data science; NLM 2017-2027 Strategic Planning; the National Network of Libraries of Medicine; & NLM-wide projects.
The NLM Update slides are available.
Patricia Flatley Brennan, Director, National Library of Medicine (slides: 1 – 15)
Joyce Backus, Associate Director for Library Operations (slides: 16 – 46)
Amanda J. Wilson, Head, National Network Coordinating Office of the National Network of Libraries of Medicine (slides: 47 – 58)

New Website Design for the NLM Disaster Information Management Research Center

The National Library of Medicine released a new design for the Disaster Information Management Research Center website & the Disaster Lit® database.  The new design improves access to key resources on natural and man-made disasters, as well as public health emergencies such as emerging infectious diseases. 
The Disaster Lit database complements PubMed with information from hundreds of sources concerning disasters and public health emergencies. Over 14,000 reports, guidelines, training courses, websites, etc., from government agencies, non-governmental organizations, universities, and more are included in Disaster Lit.
We keep our Disaster Health Information Guides up to date by linking directly to searches of Disaster Lit and PubMed. This ensures that the latest articles & resources are always at your fingertips.
Want to keep up to date with DIMRC? Join our announcement list, or the weekly or daily Disaster Lit update digest, and follow us on Twitter: https://disasterinfo.nlm.nih.gov/stay-connectedv

Since its founding in 1836, the National Library of Medicine https://www.nlm.nih.gov has played a pivotal role in translating biomedical research into practice and is a leader in information innovation. NLM is the world’s largest medical library, & millions of scientists, health professionals and the public around the world use NLM services every day.
###

Genetics Home Reference: Lyme disease

Lyme disease is an infectious disease caused by Borrelia burgdorferi bacteria. The bacteria are transferred to humans by tick bite, specifically by blacklegged ticks (commonly known as deer ticks). The condition is named for the location in which it was first described, the town of Lyme, Connecticut.
If not treated with antibiotics, Lyme disease follows three stages: early localized, early disseminated, and late disseminated infection. A small percentage of individuals have symptoms that persist months or years after treatment, which is called post-treatment Lyme disease syndrome.
A characteristic feature of Lyme disease, and the key feature of early localized infection, is a slowly expanding red rash on the skin (called erythema migrans) at the site of the tick bite; the rash is often bull’s-eye shaped. Flu-like symptoms & enlarged lymph nodes (lymphadenopathy) are also early signs of infection. Most people who are treated at this stage never develop further symptoms.
The early disseminated stage of Lyme disease occurs as the bacteria is carried throughout the body in the bloodstream. This stage occurs a few weeks after the tick bite. Signs & symptoms can include additional rashes on other parts of the body, flu-like symptoms, & lymphadenopathy. Some affected individuals develop neurologic problems (referred to as neuroborreliosis), such as paralyzed muscles in the face (facial palsy); pain, numbness, or weakness in the hands or feet; difficulty concentrating; or memory problems. Rarely, the heart is affected (Lyme carditis), causing a sensation of fluttering or pounding in the chest (palpitations) or an irregular heartbeat.
The late disseminated…

Systolic Blood Pressure Intervention Trial (SPRINT) Study

In adults age 50 and older who had high blood pressure & at least one additional cardiovascular disease risk factor, but who had no history of diabetes or stroke, SPRINT showed that treating to a target systolic blood pressure of less than 120 mm Hg reduced rates of high blood pressure complications, such as heart attack, heart failure, and stroke, by 25 percent. Compared with the standard target systolic pressure of 140 mm Hg, treating to less than 120 mm Hg also lowered the risk of death by 27 percent. In 2015, the SPRINT Research Group published its findings in the New England Journal of Medicine.
The cardiovascular benefits of the lower systolic blood pressure target were consistent in all groups of people included in SPRINT, regardless of gender, race, age, or pre-existing CKD. To achieve the target systolic blood pressure of less than 120 mm Hg, the first treatment group received three medicines on average. The second treatment group received two medicines to treat to the target systolic blood pressure of less than 140 mm Hg. Participants had high levels of satisfaction with treatment and adherence to medicines regardless of which treatment group they were in.
In the lower blood pressure group, there were expected side effects from blood pressure medicines, such as lower blood levels of potassium and sodium. Treating to the target systolic blood pressure of less than 120 mm Hg also showed an increase in complications due to low blood pressure such as fainting; however, there was not…

Golden Star Wholesale Issues Allergy Alert on Undeclared Sulfites in Dried Apricots Sour

Golden Star Wholesale of Troy, MI 48084 is recalling, AL Reef  Dried Apricots Sour, because it may contain undeclared sulfites. People who have an allergy or severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product.
The recalled AL Reef  Dried Apricots Sour, 12 oz clear plastic container, un-coded were sold via retail stores in MI, NY,MN,KY,WI,FL,NC,VA,OR,MA,OH,TX,MO between November 2017 & May 2018.
No illnesses have been reported to date in connection with this problem.
The recall was initiated after routine sampling of the product by New York State Department of Agriculture & Markets food inspectors & subsequent analysis by Dept. food laboratory personnel revealed the presence of undeclared sulfites in Al Reef Dried Apricot Sour package that did not declare sulfites on the label.
Consumers who have purchased AL Reef Dried Apricot Sour should return it to the place of purchase. Consumers with questions may contact the company at 248-577-5080.
### …

What are you reading this summer?

We asked some staff here at the National Library of Medicine what was on their summer reading list, & we were thrilled by the diversity of answers.
Every list is different.
No two readers even had the same author on their lists.
Predictably, many of the titles cover science and medicine. One staffer even recommended a novel destined to get children interested in science. But you’ll also find fiction & even a bit of poetry. They tell us in their own words what books are on their summer reading list and why.
But if you’re looking for quicker reads, we’ve included a few posts from a trio of NLM blogs: Circulating Now, Musings from the Mezzanine, & NLM in Focus.
We also give you space at the end of the article to let us know what you’re reading.
As always, we’d be delighted to hear from you.
Read on. . .
Most of my summer reading will be related to my work. I am am will battle to stay current with fast-paced developments in biomedical research & even within NCBI!  As in the rest of the year, I’m will be reading the NIH Director’s Blog & Nature’s news postings. & as many scientific articles as possible!
Outside of work, my reading material will also be utilitarian: I will will be searching the web for gardening tips and for ideas on chasing various critters out of my backyard. Raccoons are my latest “interest.” But if they continue with their mad gardening in my plots, I am will reach for something more spiritual to…

The FDA Encourages New Treatments for Sickle Cell Disease

[embedded content]

Español
 Subscribe: FDA Consumer Health Information 
Sickle cell disease (SCD) is the most common inherited blood disorder in the United States. It affects about 100,000 children & adults in the United States & millions of people globe.
New treatments are needed to prevent & treat its serious complications. That’s why the U.S. Food & Drug Administration is working with patients & stakeholders, including academics & those from the pharmaceutical industry, to help.
What Is Sickle Cell Disease?
Sickle cell disease affects millions of people globe and is particularly common among people with ancestors from sub-Saharan Africa; Spanish-speaking regions in the Western Hemisphere (South America, the Caribbean, & Central America); Saudi Arabia; India; & Mediterranean countries such as Turkey, Greece, & Italy, according to the Centers for Disease Control & Prevention.
More than 3 million Americans, including one in 13 African Americans, carry the sickle cell trait, the gene that can potentially allow the disease to be passed on to their children. A baby born with sickle cell disease must inherit a SCD gene from each parent. Babies born in the United States are typically screened at birth for SCD.
People with the disease have “sickled” or abnormally shaped red blood cells that get stuck in small blood vessels & block the flow of blood & oxygen to major organs in the body. These blockages can cause severe pain, organ damage, or even stroke. Other complications include vulnerability to infection, fatigue, & delayed growth.
SCD is chronic & its severity varies. Most people with the disease will…

Heathy Casa © 2018 Frontier Theme
Do NOT follow this link or you will be banned from the site!